← Back to front page
United States · Platforms & data · Stocktwits

Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist

Published by Stocktwits · United States 9 h ago
Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist
Stocktwits

Detailed summary

Capricor and Savara face Nov.22 FDA deadlines, while Beren Therapeutics awaits a Tuesday decision on Adrabetadex.

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading